The University of The West Indies
uwi.eduTotal trials
61
Active
9
Phase 3
6
Total enrollment
10,825
Read this sponsor's pipeline like an analyst.
Generate a written report: strategic focus, priority programs, pipeline shape, recent terminations and momentum, and the trials worth watching in the next 12 months.
~15-30 sec · cached for 24h
Pipeline matrix
Showing 1 of 1 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| 20% Cassia alata cream | — | — | — | — | — | 1 |
Next readouts
- 2026-01-31
Top conditions
- Sickle Cell Disease5
- Platelet Dysfunction Due to Drugs4
- Back Pain4
- Low Back Pain4
- Musculoskeletal Pain4
- Neck Pain4
- Platelet Dysfunction3
- Diabetes Mellitus3
Frequently asked questions about The University of The West Indies
- How many clinical trials does The University of The West Indies have on ClinicalTrials.gov?
- The University of The West Indies is listed as the lead sponsor on 61 clinical trials in ClinicalTrials.gov, 9 of which are currently active (recruiting, enrolling, or ongoing).
- How many of The University of The West Indies's trials are in Phase 3?
- 6 of The University of The West Indies's trials are in Phase 3, spread across 1 active drug program.
- What therapeutic areas does The University of The West Indies focus on?
- The University of The West Indies's most-studied conditions on ClinicalTrials.gov are Sickle Cell Disease, Platelet Dysfunction Due to Drugs, Back Pain, Low Back Pain, Musculoskeletal Pain.
- When are The University of The West Indies's next clinical trial readouts?
- The University of The West Indies has 1 upcoming primary-completion readout tracked here; the soonest is “A Study of the Clinical Efficacy and Safety of 20% Cassia Alata Extract Against Tinea Versicolor”, expected around 2026-01-31.